Aarhus University Seal

Publications

Sort by: Date | Author | Title

Khan, N. L., Brooks, D. J., Pavese, N., Sweeney, M. G., Wood, N. W., Lees, A. J. & Piccini, P. (2002). Progression of nigrostriatal dysfunction in a parkin kindred: An [18F]dopa PET and clinical study. Brain, 125(10), 2248-2256.
Kew, J. J. M., Halligan, P. W., Marshall, J. C., Passingham, R. E., Rothwell, J. C., Ridding, M. C., David Marsden, C. & Brooks, D. J. (1997). Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees. Journal of Neurophysiology, 77(5), 2753-2764. https://doi.org/10.1152/jn.1997.77.5.2753
Kew, J. J. M., Brooks, D. J., Rassingham, R. E., Rothwell, J. C., Frackowiak, R. S. J. & Leigh, P. N. (1994). Cortical function in progressive muscular atrophy and amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 124(SUPPL.). https://doi.org/10.1016/0022-510X(94)90184-8
Kew, J. J. M., Ridding, M. C., Rothwell, J. C., Passingham, R. E., Leigh, P. N., Sooriakumaran, S., Frackowiak, R. S. J. & Brooks, D. J. (1994). Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation. Journal of Neurophysiology, 72(5), 2517-2524. https://doi.org/10.1152/jn.1994.72.5.2517
Kew, J. J. M., Leigh, P. N., Playford, E. D., Passingham, R. E., Goldstein, L. H., Frackowiak, R. S. J. & Brooks, D. J. (1993). Cortical function in amyotrophic lateral sclerosis: A positron emission tomography study. Brain, 116(3), 655-680. https://doi.org/10.1093/brain/116.3.655
Kew, J., Morris, C., Aihie, A., Fysh, R., Jones, S. & Brooks, D. (1993). Arsenic and mercury intoxication due to Indian ethnic remedies. British Medical Journal, 306(6876), 506-507.
Jueptner, M., Stephan, K. M., Frith, C. D., Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1997). Anatomy of motor learning. I. Frontal cortex and attention to action. Journal of Neurophysiology, 77(3), 1313-1324. https://doi.org/10.1152/jn.1997.77.3.1313
Jueptner, M., Frith, C. D., Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1997). Anatomy of motor learning. II. Subcortical structures and learning by trial and error. Journal of Neurophysiology, 77(3), 1325-1337. https://doi.org/10.1152/jn.1997.77.3.1325
Jueptner, M., Jenkins, I. H., Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1996). The sensory guidance of movement: A comparison of the cerebellum and basal ganglia. Experimental Brain Research, 112(3), 462-474. https://doi.org/10.1007/BF00227952
Jost, S. T., Visser-Vandewalle, V., Rizos, A., Loehrer, P. A., Silverdale, M., Evans, J., Samuel, M., Petry-Schmelzer, J. N., Sauerbier, A., Gronostay, A., Barbe, M. T., Fink, G. R., Ashkan, K., Antonini, A., Martinez-Martin, P., Chaudhuri, K. R., Timmermann, L., Dafsari, H. S. & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2021). Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. Parkinson's Disease, 7(1), Article 48. https://doi.org/10.1038/s41531-021-00174-x
Josefsen, L. G., Møller, A. & Linnet, J. (2008). Cognitive bias in poker. Poster session presented at 8th annual NCRG conference on pathological gambling, Las Vegas, United States.
Josefsen, L. G., Møller, A. & Linnet, J. (2008). Pathological Gambling: Cognitive bias and neurobiological correlates. Poster session presented at Forskningens dag på Århus Universitets Hospital, Århus, Denmark.
Johnston, S. R. D., Burn, D. J. & Brooks, D. J. (1991). Peripheral neuropathy associated with lithium toxicity [7]. Journal of Neurology Neurosurgery and Psychiatry, 54(11), 1019-1020. https://doi.org/10.1136/jnnp.54.11.1019
Johansen, J., Rosenblad, C., Andsberg, K., Møller, A., Lundberg, C., Björlund, A. & Johansen, TE. (2002). Evaluation on Tet-on system to avoid transgene downregulation in ex vivo gene transfer to the CNS. Gene Therapy, 9, 1291-1301.
Johansen, J., Tornøe, J., Møller, A. & Johansen, T. E. (2003). Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements. The Journal of Gene Medicine, 5, 1080-1089.
Jiang, R., Chazot, P., Pavese, N., Crookes, D., Bouridane, A. & Celebi, M. E. (2022). Private Facial Prediagnosis as an Edge Service for Parkinson's DBS Treatment Valuation. IEEE Journal of Biomedical and Health Informatics, 26(6), 2703-2713. https://doi.org/10.1109/JBHI.2022.3146369
Jesuthasan, A., Garcia, L. R. & Pavese, N. (2022). Studying cognitive function in patients with a long-standing diagnosis of SWEDD. Journal of the Neurological Sciences, 441, Article 120353. https://doi.org/10.1016/j.jns.2022.120353
Jensen, P. K., Møller, A., Gram, L. & Jensen, N. O. (1990). Pharmacokinetic comparison of two carbamazepine slow-release formulations. Acta Neurologica Scandinavica. Supplementum, 82, 135-7.
Jenner, P., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben-Shlomo, Y., Bolam, P., Burn, D., Hindle, J. V. & Brooks, D. (2013). Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. Journal of Parkinson's Disease, 3(1), 1-11. https://doi.org/10.3233/JPD-130175
Jenkins, I. H., Brooks, D. J., Nixon, P. D., Frackowiak, R. S. J. & Passingham, R. E. (1994). Motor sequence learning: A study with positron emission tomography. Journal of Neuroscience, 14(6), 3775-3790.
Janson, A. M., Møller, A., Hedlund, P. B. & von Euler, G. (1995). Effect of nicotine on biological systems II. Birkhäuser Verlag, 321-328.
Jansen, W. J., Ossenkoppele, R., Tijms, B. M., Fagan, A. M., Hansson, O., Klunk, W. E., van der Flier, W. M., Villemagne, V. L., Frisoni, G. B., Fleisher, A. S., Lleó, A., Mintun, M. A., Wallin, A., Engelborghs, S., Na, D. L., Chételat, G., Molinuevo, J. L., Landau, S. M., Mattsson, N. ... Amyloid Biomarker Study Group (2018). Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. J A M A Psychiatry, 75(1), 84-95. https://doi.org/10.1001/jamapsychiatry.2017.3391
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J. & Amyloid Biomarker Study Group (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology, 79(3), 228-243. https://doi.org/10.1001/jamaneurol.2021.5216
Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J. ... Morris, H. R. (2020). Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology, 77(3), 377-387. https://doi.org/10.1001/jamaneurol.2019.4347
Jabbari, E., Woodside, J., Tan, M. M. X., Pavese, N., Bandmann, O., Ghosh, B. C. P., Massey, L. A., Capps, E., Warner, T. T., Lees, A. J., Revesz, T., Holton, J. L., Williams, N. M., Grosset, D. G. & Morris, H. R. (2019). The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. Movement Disorders, 34(9), 1307-1314. https://doi.org/10.1002/mds.27786
Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y., Hatano, K., Abe, Y., Yamada, T., Kachi, T. & Brooks, D. J. (2002). Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study. Brain, 125(6), 1358-1365. https://doi.org/10.1093/brain/awf134
Ito, K., Morrish, P. K., Rakshi, J. S., Uema, T., Ashburner, J., Bailey, D. L., Friston, K. J. & Brooks, D. J. (1999). Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 66(6), 754-758. https://doi.org/10.1136/jnnp.66.6.754
Isaacs, J. D., Rakshi, J., Baker, R., Brooks, D. J. & Warrens, A. N. (2005). Chorea associated with thyroxine replacement therapy. Movement Disorders, 20(12), 1656-1657. https://doi.org/10.1002/mds.20603
Ikoma, Y., Edison, P., Ramlackhansingh, A., Brooks, D. J. & Turkheimer, F. E. (2013). Reference region automatic extraction in dynamic [(11)C]PIB. Journal of Cerebral Blood Flow and Metabolism, 33(11), 1725-31. https://doi.org/10.1038/jcbfm.2013.133
Hyare, H., Ramlackhansingh, A., Gelosa, G., Edison, P., Rudge, P., Brandner, S., Brooks, D. J., Collinge, J. & Mead, S. (2012). 11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery & Psychiatry, 83(3), 340-1. https://doi.org/10.1136/jnnp.2010.233692
Hvingelby, V., Carra, R. B., Terkelsen, M. H., Hamani, C., Capato, T., Košutzká, Z., Krauss, J. K., Moro, E., Pavese, N., Cury, R. G. & Gait Study Group (2024). A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies. Movement Disorders Clinical Practice, 11(8), 927-947. https://doi.org/10.1002/mdc3.14143
Huo, W., Angeles, P., Tai, Y. F., Pavese, N., Wilson, S., Hu, M. T. & Vaidyanathan, R. (2020). A Heterogeneous Sensing Suite for Multisymptom Quantification of Parkinson's Disease. I E E E Transactions on Neural Systems and Rehabilitation Engineering, 28(6), 1397-1406. Article 9064818. https://doi.org/10.1109/TNSRE.2020.2978197
Hume, S. P., Luthra, S. K., Brown, D. J., Opacka-Juffry, J., Osman, S., Ashworth, S., Myers, R., Brady, F., Carroll, F. I., Kuhar, M. J. & Brooks, D. J. (1996). Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Nuclear Medicine and Biology, 23(3), 377-384. https://doi.org/10.1016/0969-8051(96)00019-4
Hu, M. T. M., Scherfler, C., Khan, N. L., Hajnal, J. V., Lees, A. J., Quinn, N., Wood, N. W. & Brooks, D. J. (2006). Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease. Movement Disorders, 21(3), 299-305. https://doi.org/10.1002/mds.20702
Hu, M. T. M., Chaudhuri, K. R., Jorosz, J., Yaguez, L. & Brooks, D. J. (2002). An imaging study of parkinsonism among African-Caribbean and Indian London communities. Movement Disorders, 17(6), 1321-1328. https://doi.org/10.1002/mds.10261
Hu, M. T. M., White, S. J., Chaudhuri, K. R., Morris, R. G., Bydder, G. M. & Brooks, D. J. (2001). Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. Journal of Neural Transmission, 108(5), 571-580. https://doi.org/10.1007/s007020170057
Hu, M. T. M., White, S. J., Herlihy, A. H., Chaudhuri, K. R., Hajnal, J. V. & Brooks, D. J. (2001). A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of parkinson's disease. Neurology, 56(9), 1195-1200. https://doi.org/10.1212/WNL.56.9.1195
Hu, M. T. M., Taylor-Robinson, S. D., Chaudhuri, K. R., Bell, J. D., Labbé, C., Cunningham, V. J., Koepp, M. J., Hammers, A., Morris, R. G., Turjanski, N. & Brooks, D. J. (2000). Cortical dysfunction in non-demented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET study. Brain, 123(2), 340-352. https://doi.org/10.1093/brain/123.2.340
Hu, M. T. M., Taylor-Robinson, S. D., Ray Chaudhuri, K., Bell, J. D., Morris, R. G., Clough, C., Brooks, D. J. & Turjanski, N. (1999). Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study. Journal of Neurology Neurosurgery and Psychiatry, 67(1), 20-26. https://doi.org/10.1136/jnnp.67.1.20
Holden, J. E., Jakobsen, S., Alstrup, A. K. O., Doudet, D. & Landau, A. M. (2011). Tracer kinetic responses to propofol-induced reduction of brain perfusion: Comparison of [11C]Yohimbine and [11C]SCH23390. Abstract from XXVth International Symposium on Cerebral Blood Flow, Metabolism and Function and the Xth International Conference on Quantification of Brain Function with PET, Barcelona, Spain.
Hirani, E., Gillies, J., Karasawa, A., Shimada, J., Kase, H., Opacka-Juffry, J., Osman, S., Luthra, S. K., Hume, S. P. & Brooks, D. J. (2001). Evaluation of [4-O-methyl-11C]KW-6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats. Synapse, 42(3), 164-176. https://doi.org/10.1002/syn.1110
Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G. C. ... Kummer, M. P. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology, 14(4), 388-405.
Helmich, R. C., Vaillancourt, D. E. & Brooks, D. J. (2018). The future of brain imaging in Parkinson's disease. Journal of Parkinson's Disease, 8(s1), S47-S51. https://doi.org/10.3233/JPD-181482
Hansen, A., Knudsen, K., Fedorova, T. D., Parbo, P., Østergaard, K., Brooks, D. & Borghammer, P. (2016). In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Poster session presented at International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany.
Hammers, A., Panagoda, P., Heckemann, R. A., Kelsch, W., Turkheimer, F. E., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2008). [11C]Flumazenil PET in temporal lobe epilepsy: Do we need an arterial input function or kinetic modeling? Journal of Cerebral Blood Flow and Metabolism, 28(1), 207-216. https://doi.org/10.1038/sj.jcbfm.9600515
Hammers, A., Asselin, M. C., Turkheimer, F. E., Hinz, R., Osman, S., Hotton, G., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007). Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test-retest data. NeuroImage, 38(1), 82-94. https://doi.org/10.1016/j.neuroimage.2007.06.035
Hammers, A., Asselin, M. C., Hinz, R., Kitchen, I., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007). Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain, 130(4), 1009-1016. https://doi.org/10.1093/brain/awm012
Hammers, A., Chen, C. H., Lemieux, L., Allom, R., Vossos, S., Free, S. L., Myers, R., Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007). Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space. Human Brain Mapping, 28(1), 34-48. https://doi.org/10.1002/hbm.20254
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J. & Duncan, J. S. (2003). Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human Brain Mapping, 19(4), 224-247. https://doi.org/10.1002/hbm.10123
Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R., Brooks, D. J. & Duncan, J. S. (2003). Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain, 126(6), 1300-1318. https://doi.org/10.1093/brain/awg138
Hammers, A., Koepp, M. J., Hurlemann, R., Thom, M., Richardson, M. P., Brooks, D. J. & Duncan, J. S. (2002). Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain, 125(10), 2257-2271. https://doi.org/10.1093/brain/awf233
Hammers, A., Koepp, M. J., Free, S. L., Brett, M., Richardson, M. P., Labbé, C., Cunningham, V. J., Brooks, D. J. & Duncan, J. (2002). Implementation and application of a brain template for multiple volumes of interest. Human Brain Mapping, 15(3), 165-174. https://doi.org/10.1002/hbm.10016
Hammers, A., Koepp, M. J., Richardson, M. P., Labbé, C., Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (2001). Central benzodiazepine receptors in malformations of cortical development: A quantitative study. Brain, 124(8), 1555-1565.
Hammers, A., Koepp, M. J., Labbé, C., Brooks, D. J., Thom, M., Cunningham, V. J. & Duncan, J. S. (2001). Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology, 56(7), 897-906. https://doi.org/10.1212/WNL.56.7.897
Hamdy, S., Rothwell, J. C., Brooks, D. J., Bailey, D., Aziz, Q. & Thompson, D. G. (1999). Identification of the cerebral loci processing human swallowing with H2 15O PET activation. Journal of Neurophysiology, 81(4), 1917-1926. https://doi.org/10.1152/jn.1999.81.4.1917
Hagell, P., Crabb, L., Pogarell, O., Schrag, A., Widner, H., Brooks, D. J., Oertel, W. H., Quinn, N. P. & Lindvall, O. (2000). Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. Movement Disorders, 15(2), 224-229. https://doi.org/10.1002/1531-8257(200003)15:2<224::AID-MDS1004>3.0.CO;2-W
Hagell, P., Schrag, A., Piccini, P., Jahanshahi, M., Brown, R., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Odin, P., Wenning, G. K., Morrish, P., Gustavii, B., Björklund, A., Brooks, D. J., Marsden, C. D., Quinn, N. P. & Lindvall, O. (1999). Sequential bilateral transplantation in Parkinson's disease. Effects of the second graft. Brain, 122(6), 1121-1132. https://doi.org/10.1093/brain/122.6.1121
Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L., Pavese, N., Oertel, W. H., Quinn, N., Brooks, D. J. & Lindvall, O. (2002). Dyskinesias following neural transplantation in parkinson’s disease. Nature Neuroscience, 5(7), 627-628. https://doi.org/10.1038/nn863
Grover, V. P. B., Pavese, N., Koh, S.-B., Wylezinska, M., Saxby, B. K., Gerhard, A., Forton, D. M., Brooks, D. J., Thomas, H. C. & Taylor-Robinson, S. D. (2012). Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. Journal of Viral Hepatitis, 19(2), e89-96. https://doi.org/10.1111/j.1365-2893.2011.01510.x
Grønborg, M., Johansen, T. E., Peters, D., Ahring, P. K., Drejer, J., Møller, A. & Jensen, L. H. (1999). Neuroprotection by a novel compound, NS5211. The Journal of Pharmacology and Experimental Therapeutics, 290, 348-353.
Gredal, H., Thomsen, B. B., Boza-Serrano, A., Garosi, L., Rusbridge, C., Anthony, D., Møller, A., Finsen, B., Deierborg, T., Lambertsen, K. L. & Berendt, M. (2017). Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke. NeuroReport, 28(3), 134-140. https://doi.org/10.1097/WNR.0000000000000728
Grecchi, E., Doyle, O. M., Bertoldo, A., Pavese, N. & Turkheimer, F. E. (2014). Brain shaving: Adaptive detection for brain PET data. Physics in Medicine and Biology, 59(10), 2517-2534. https://doi.org/10.1088/0031-9155/59/10/2517
Grasby, P. M., Koepp, M. J., Gunn, R. N., Cunningham, V. J., Lawrence, A. D., Dagher, A., Jones, T., Brooks, D. J. & Bench, C. J. (1998). Evidence for dopamine release during a videogame using [11C]Raclopride PET. NeuroImage, 7(4 PART II).
Goerendt, I. K., Lawrence, A. D., Mehta, M. A., Stern, J. S., Odin, P. & Brooks, D. J. (2006). Distributed neural actions of anti-parkinsonian therapies as revealed by PET. Journal of Neural Transmission, 113(1), 75-86. https://doi.org/10.1007/s00702-005-0305-5
Goerendt, I. K., Messa, C., Lawrence, A. D., Grasby, P. M., Piccini, P. & Brooks, D. J. (2003). Dopamine release during sequential finger movements in health and Parkinson's disease: A PET study. Brain, 126(2), 312-325. https://doi.org/10.1093/brain/awg035
Giorgi, F. S., Biagioni, F., Galgani, A., Pavese, N., Lazzeri, G. & Fornai, F. (2020). Locus coeruleus modulates neuroinflammation in parkinsonism and dementia. International Journal of Molecular Sciences , 21(22), 1-21. Article 8630. https://doi.org/10.3390/ijms21228630
Giorgi, F. S., Martini, N., Lombardo, F., Galgani, A., Bastiani, L., Della Latta, D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi-Allegra, S., Pavese, N. & Fornai, F. (2022). Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach. Journal of Neural Transmission, 129(4), 387-394. https://doi.org/10.1007/s00702-022-02486-5
Giorgi, F. S., Lombardo, F., Galgani, A., Hlavata, H., Della Latta, D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., Scalese, M., Bastiani, L., Keilberg, P., De Marchi, D., Fornai, F. & Bonuccelli, U. (2022). Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects. Brain Imaging and Behavior, 16(3), 1077-1087. https://doi.org/10.1007/s11682-021-00562-0
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., Kaufmann, H., Klockgether, T., Lees, A., Poewe, W., Quinn, N., Revesz, T., Robertson, D., Sandroni, P., Seppi, K. & Vidailhet, M. (2008). Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 71(9), 670-676. https://doi.org/10.1212/01.wnl.0000324625.00404.15
Gillies, J., Luthra, S. K., Brady, F. & Brooks, D. J. (1999). Radiosynthesis of the dopamine D1 agonist R-(+)-[11C]SKF 82957. - A simple [11C]methylation? Journal of Labelled Compounds and Radiopharmaceuticals, 42(SUPPL. 1).
Gillies, J., Luthra, S. K., Brady, F., Karasawa, A., Shimada, J., Kase, H. & Brooks, D. J. (1999). Radiolabelling of KW-6002 with [11C]iodomethane for studies of the adenosine A(2A) receptor in vivo. Journal of Labelled Compounds and Radiopharmaceuticals, 42(SUPPL. 1).
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003). Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nature Medicine, 9(5), 589-595. https://doi.org/10.1038/nm850
Giladi, N., Tal, J., Azulay, T., Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W. H., Stocchi, F. & Tolosa, E. (2009). Validation of the Freezing of Gait Questionnaire in patients with Parkinson's disease. Movement Disorders, 24(5), 655-661. https://doi.org/10.1002/mds.21745
Ghadery, C., Best, L. A., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases. Current Neurology and Neuroscience Reports, 19(7), Article 38. https://doi.org/10.1007/s11910-019-0951-x
Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T. D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D. J., Okamura, N., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder. European Journal of Neurology, 27(4), 644-652. https://doi.org/10.1111/ene.14127
Gerhard, A., Trender-Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P. & Brooks, D. J. (2006). In vivo imaging of microglial activation with [11C]-PK11195 PET progresive supranuclear palsy. Movement Disorders, 21(1), 89-93. https://doi.org/10.1002/mds.20668
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B. & Brooks, D. J. (2006). In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiology of Disease, 21(2), 404-412. https://doi.org/10.1016/j.nbd.2005.08.002
Gerhard, A., Watts, J., Trender-Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K. & Brooks, D. J. (2004). In vivo imaging of microglial activation with [11C](R -PK11195 PET in corticobasal degeneration. Movement Disorders, 19(10), 1221-1226. https://doi.org/10.1002/mds.20162
Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N., Schwarz, J. & Brooks, D. J. (2003). [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology, 61(5), 686-689. https://doi.org/10.1212/01.WNL.0000078192.95645.E6
Gelosa, G. & Brooks, D. J. (2012). The prognostic value of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging, 39(7), 1207-19. https://doi.org/10.1007/s00259-012-2108-x
Garvey, L. J., Pavese, N., Ramlackhansingh, A., Thomson, E., Allsop, J. M., Politis, M., Kulasegaram, R., Main, J., Brooks, D. J., Taylor-Robinson, S. D. & Winston, A. (2012). Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation. PLoS One, 7(7), e38980. https://doi.org/10.1371/journal.pone.0038980
Galgani, A., Vergallo, A., Campese, N., Lombardo, F., Pavese, N., Petrozzi, L., LoGerfo, A., Franzini, M., Cecchetti, D., Puglisi-Allegra, S., Busceti, C. L., Siciliano, G., Tognoni, G., Baldacci, F., Lista, S., Hampel, H., Fornai, F. & Giorgi, F. S. (2022). Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum. Journal of Neurochemistry, 163(1), 40-52. https://doi.org/10.1111/jnc.15686
Galgani, A., Lombardo, F., Martini, N., Vergallo, A., Bastiani, L., Hampel, H., Hlavata, H., Baldacci, F., Tognoni, G., De Marchi, D., Ghicopulos, I., De Cori, S., Biagioni, F., Busceti, C. L., Ceravolo, R., Bonuccelli, U., Chiappino, D., Siciliano, G., Fornai, F. ... Giorgi, F. S. (2023). Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia. European Journal of Neurology, 30(1), 32-46. https://doi.org/10.1111/ene.15556
Galgani, A., Palermo, G., Lombardo, F., Martini, N., Bastiani, L., Vergallo, A., Tommasini, L., Bellini, G., Baldacci, F., Frosini, D., Tognoni, G., Gesi, M., Cademartiri, F., Fornai, F., Pavese, N., Ceravolo, R. & Giorgi, F. S. (2023). Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies. Current Alzheimer research, 20(4), 277-288. https://doi.org/10.2174/1567205020666230721144603
Galgani, A., Lombardo, F., Frijia, F., Martini, N., Tognoni, G., Pavese, N. & Giorgi, F. S. (2024). The degeneration of locus coeruleus occurring during Alzheimer’s disease clinical progression: a neuroimaging follow-up investigation. Brain Structure & Function, 229(5), 1317-1325. https://doi.org/10.1007/s00429-024-02797-1
Galgani, A., Lombardo, F., Frijia, F., Scotto, M., Tognoni, G., Pavese, N. & Giorgi, F. S. (2025). Locus Coeruleus Sexual Dimorphism and Its Impact on Cognitive Impairment and Cortical Atrophy in Alzheimer's Disease. Neurodegenerative Diseases, 25(2), 53-66. https://doi.org/10.1159/000544882
Fuxe, K., Chadi, G., Agnati, L. F., Tinner, B., Rosén ., Janson, A. M., Møller, A., Cintra, A., Cao, Y., Goldstein, M., Lindahl, U., David, G., Ögren, O., Toffano, G., Baird, A. & Pettersson, R. F. (1994). Fibroblast growth factor-2, ganglioside GM1 and the trophic regulation of the basal ganglia. Focus on the nigrostriatal dopamine neurons. Pergamon Press, 62, 1-42.
Frisoni, G. B., Bocchetta, M., Chételat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E., Brooks, D. J., Carrillo, M. C., Fox, N. C., Herholz, K., Nordberg, A., Jack, C. R., Jagust, W. J., Johnson, K. A., Rowe, C. C. ... ISTAART's NeuroImaging Professional Interest Area (2013). Imaging markers for Alzheimer disease: which vs how. Neurology, 81(5), 487-500. https://doi.org/10.1212/WNL.0b013e31829d86e8
Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Kriek, E., qi, J. X., Lone, T., Zhang, Y. B., Snyder, J. A., Wells, T. H., Ramig, L. O., Thompson, L., Mazziotta, J. C., Huang, S. C., Grafton, S. T., Brooks, D., Sawle, G., Schroter, G. & Ansari, A. A. (1992). Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months after Transplantation for Parkinson's Disease. New England Journal of Medicine, 327(22), 1549-1555. https://doi.org/10.1056/NEJM199211263272202
Fox, T., Siderowf, A. D., Fernandez, H. H., Tanner, C. M., Postuma, R. B., Simon, D. K., Byrne, M., Lang, A. E., Brooks, D., Rascol, O., Tolosa, E., Poewe, W., Stocchi, F., Mollenhauer, B., Giladi, N., Hirschhorn, B., Cedarbaum, J. M., Nomikos, G., Fanning, L. ... Brys, M. (2020). Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson's Disease (1579). Neurology, 94(15).
Fleischhacker, W. W. & Brooks, D. J. (2003). Addiction. Mechanisms, phenomenology and treatment: Preface. Journal of Neural Transmission, Supplement, (66).
Fleischhacker, W. W. & Brooks, D. (2003). Neuropsychopharmacology: Preface. Journal of Neural Transmission, Supplement, (64).
Firbank, M. J., Yarnall, A. J., Lawson, R. A., Duncan, G. W., Khoo, T. K., Petrides, G. S., O'Brien, J. T., Barker, R. A., Maxwell, R. J., Brooks, D. J. & Burn, D. J. (2017). Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study. Journal of Neurology, Neurosurgery & Psychiatry, 88(4), 310-316. https://doi.org/10.1136/jnnp-2016-313918
Firbank, M. J., Pasquini, J., Best, L., Foster, V., Sigurdsson, H. P., Anderson, K. N., Petrides, G., Brooks, D. J. & Pavese, N. (2024). Cerebellum and basal ganglia connectivity in isolated REM sleep behaviour disorder and Parkinson's disease: an exploratory study. Brain Imaging and Behavior, 18(6), 1428-1437. https://doi.org/10.1007/s11682-024-00939-x
Femminella, G. D., Ninan, S., Atkinson, R., Fan, Z., Brooks, D. J. & Edison, P. (2016). Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? Journal of Alzheimer's Disease, 51(4), 1275-1289. https://doi.org/10.3233/JAD-150827
Femminella, G. D., Dani, M., Wood, M., Fan, Z., Calsolaro, V., Atkinson, R., Edginton, T., Hinz, R., Brooks, D. J. & Edison, P. (2019). Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology, 92(12), E1331-E1343. https://doi.org/10.1212/WNL.0000000000007133
Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2019). Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 20(1), Article 191. https://doi.org/10.1186/s13063-019-3259-x
Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21, Article 660. https://doi.org/10.1186/s13063-020-04608-4
Femminella, G. D., Livingston, N. R., Raza, S., van der Doef, T., Frangou, E., Love, S., Busza, G., Calsolaro, V., Carver, S., Holmes, C., Ritchie, C. W., Lawrence, R. M., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E. ... Edison, P. (2021). Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy, 13(1), Article 47. https://doi.org/10.1186/s13195-021-00784-w
Feeney, C., Scott LeBlanc, G., Raffel, J., Roberts, S., Coello, C., Jolly, A., Searle, G., Goldstone, A. P., Brooks, D. J., Nicholas, R. S., Trigg, W., Gunn, R. N. & Sharp, D. J. (2016). Kinetic analysis of the translocator protein positron emission tomography ligand [F-18]GE-180 in the human brain. European journal of nuclear medicine and molecular imaging, 43(12), 2201-2210. https://doi.org/10.1007/s00259-016-3444-z
Fearnley, J. M., Revesz, T., Brooks, D. J., Frackowiak, R. S. J. & Lees, A. J. (1991). Diffuse Lewy body disease presenting with a supranuclear gaze palsy. Journal of Neurology Neurosurgery and Psychiatry, 54(2), 159-161. https://doi.org/10.1136/jnnp.54.2.159
Fast, R., Rodell, A., Alstrup, A. K. O., Berendt, M. & Møller, A. (2011). Dementia in geriatric canines. Abstract from Tenth OAK Annual Meeting, Aarhus C, Denmark.
Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J. & Edison, P. (2014). Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2014.06.016
Fan, Z., Calsolaro, V., Atkinson, R. A., Femminella, G. D., Waldman, A., Buckley, C. J., Trigg, W., Brooks, D. J., Hinz, R. & Edison, P. (2016). Flutriciclamide (F-18-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein. Journal of Nuclear Medicine, 57(11), 1753-1759. https://doi.org/10.2967/jnumed.115.169078
Fan, Z., Dani, M., Femminella, G. D., Wood, M., Calsolaro, V., Veronese, M., Turkheimer, F., Gentleman, S., Brooks, D. J., Hinz, R. & Edison, P. (2018). Parametric mapping using spectral analysis for C-11-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects. European Journal of Nuclear Medicine and Molecular Imaging, 45(8), 1432-1441. https://doi.org/10.1007/s00259-018-3984-5
Fan, Z., Harold, D., Pasqualetti, G., Williams, J., Brooks, D. J. & Edison, P. (2015). Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort? Journal of Nuclear Medicine, 56(5), 707-713. https://doi.org/10.2967/jnumed.114.149443
Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., Brooks, D. J., Lees, A. J. & Piccini, P. (2006). Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Annals of Neurology, 59(5), 852-858. https://doi.org/10.1002/ana.20822
Eskildsen, S., Iranzo, A., Stokholm, M., Staer, K., Ostergaard, K., Eroles, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Borghammer, P., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Tolosa, E., Ostergaard, L. & Pavese, N. (2019). Occurrence of brain capillary dysfunction in patients with REM sleep behavior disorder. S786-S787. Abstract from International Congress of Parkinson's Disease and Movement Disorders, Nice, France.
Ellis, E. G., Meyer, G. M., Kaasinen, V., Corp, D. T., Pavese, N., Reich, M. M. & Joutsa, J. (2024). Multimodal neuroimaging to characterize symptom-specific networks in movement disorders. npj Parkinson's Disease , 10(1), Article 154. https://doi.org/10.1038/s41531-024-00774-3
Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., Walker, Z., Turkheimer, F. E. & Brooks, D. J. (2013). Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia. Neuropsychopharmacology, 38(6), 938-49. https://doi.org/10.1038/npp.2012.255
Edison, P., Hinz, R., Ramlackhansingh, A., Thomas, J., Gelosa, G., Archer, H. A., Turkheimer, F. E. & Brooks, D. J. (2012). Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans? NeuroImage, 60(3), 1716-23. https://doi.org/10.1016/j.neuroimage.2012.01.099
Edison, P., Carter, S. F., Rinne, J. O., Gelosa, G., Herholz, K., Nordberg, A., Brooks, D. J. & Hinz, R. (2013). Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. NeuroImage, 70, 423-33. https://doi.org/10.1016/j.neuroimage.2012.12.014
Edison, P., Hinz, R. & Brooks, D. J. (2011). Technical aspects of amyloid imaging for Alzheimer's disease. Alzheimer's Research & Therapy, 3(4), Article 25. https://doi.org/10.1186/alzrt87
Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., Rossor, M. & Brooks, D. J. (2008). Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiology of Disease, 32(3), 412-419. https://doi.org/10.1016/j.nbd.2008.08.001
Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., Villemagne, V. L., O'Keefe, G., Någren, K., Chaudhury, K. R., Masters, C. L. & Brooks, D. J. (2008). Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Journal of Neurology, Neurosurgery & Psychiatry, 79(12), 1331-1338. https://doi.org/10.1136/jnnp.2007.127878
Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., Rossor, M. & Brooks, D. J. (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology, 68(7), 501-508. https://doi.org/10.1212/01.wnl.0000244749.20056.d4
Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W., Brooks, D. J., Pavese, N., Burn, D. J. & ICICLE-PD Study Group (2019). Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease. European Journal of Neurology, 26(7), 979-985. https://doi.org/10.1111/ene.13919
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A. & Burn, D. J. (2014). Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Movement Disorders, 29(2), 195-202. https://doi.org/10.1002/mds.25664
Duncan, G. W., Firbank, M. J., Yarnall, A. J., Khoo, T. K., Brooks, D. J., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2016). Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Movement Disorders, 31(1), 103-110. https://doi.org/10.1002/mds.26312
Doudet, D., Landau, A. M., Dyve, S., Jakobsen, S., Alstrup, A. K. O. & Gjedde, A. (2011). Long term decrease in alpha 2 receptor distribution volume after acute stimulation of NA release. Abstract from XXVth International Symposium on Cerebral Blood Flow, Metabolism and Function and the Xth International Conference on Quantification of Brain Function with PET, Barcelona, Spain.